Huntington Disease Basal Ganglia Pathology

Huntington disease (HD) is a devastating neurodegenerative disorder that serves as a paradigm for understanding genetic anticipation, basal ganglia dysfunction, and movement disorders. For medical students and MCAT examinees, mastering HD pathology is essential, as it integrates concepts from genetics, neuroanatomy, and clinical medicine. This knowledge not only aids in patient care but also helps you tackle high-yield questions on standardized exams.

Genetic Foundation and Molecular Mechanism

Huntington disease is an autosomal dominant disorder, meaning that a single mutated copy of the gene inherited from one parent is sufficient to cause the disease. This mutation involves a CAG trinucleotide repeat expansion in the huntingtin gene (HTT) located on chromosome four. In unaffected individuals, the CAG segment repeats 10 to 35 times, but in HD, repeats of 40 or more lead to disease with complete penetrance. The expanded CAG repeats result in an abnormal huntingtin protein with a elongated polyglutamine tract, which is toxic to neurons, particularly in the striatum. A key concept for the MCAT is genetic anticipation, where successive generations may show earlier onset and increased severity due to repeat expansion during meiosis. For example, a parent with 42 repeats might have a child with 50 repeats, leading to juvenile-onset HD. Understanding this molecular basis is crucial for genetic counseling and predicting disease progression.

Basal Ganglia Circuitry and Pathological Disruption

To comprehend HD symptoms, you must first grasp the normal basal ganglia circuitry, a group of subcortical nuclei that regulate movement. The striatum, composed of the caudate nucleus and putamen, receives input from the cortex and uses GABAergic (gamma-aminobutyric acid) neurons to modulate output via direct and indirect pathways. In HD, there is selective degeneration of GABAergic neurons in the caudate nucleus, which early in the disease disproportionately affects the indirect pathway. Think of the indirect pathway as a "brake" on movement; its disruption removes inhibition, causing excessive motor activity. This imbalance between direct and indirect pathways leads to hyperkinesia, manifesting as chorea. For the MCAT, remember that the caudate is part of the associative striatum involved in cognitive functions, explaining why HD also causes dementia. Anatomically, imaging shows characteristic caudate atrophy, which you might be asked to identify in exam vignettes.

Clinical Presentation and Disease Progression

The classic triad of HD includes chorea, progressive dementia, and psychiatric symptoms. Chorea refers to involuntary, rapid, dance-like movements that are random and unpredictable, often starting subtly in the face and limbs. As the disease advances, chorea may give way to bradykinesia and rigidity. Cognitive decline typically begins with executive dysfunction, like planning and multitasking deficits, escalating to severe dementia. Psychiatric manifestations such as depression, anxiety, irritability, and psychosis are common and can precede motor symptoms. Consider this patient vignette: a 45-year-old presents with mild fidgeting, forgetfulness, and mood swings; recognizing this pattern is key for early diagnosis. On the MCAT, you may encounter questions linking specific symptoms to basal ganglia pathology, so emphasize that chorea is not the only feature—cognitive and psychiatric changes are integral.

Diagnostic and Management Approaches

Diagnosis relies on a combination of clinical evaluation, family history, and genetic testing to confirm CAG repeat expansion. Neuroimaging like MRI often reveals caudate atrophy, supporting the diagnosis. There is no cure for HD, so management focuses on symptomatic treatment and supportive care. Chorea may be managed with medications like tetrabenazine or deutetrabenazine, which deplete dopamine, but these can worsen depression. Multidisciplinary care involving neurologists, psychiatrists, physical therapists, and genetic counselors is essential. For the MCAT, be prepared for questions on genetic testing ethics, such as presymptomatic testing implications, and on pharmacology—know that antipsychotics might be used for psychosis but carry risks. Understanding that treatment is palliative underscores the importance of genetic counseling and research into disease-modifying therapies.

MCAT Focus: High-Yield Concepts and Common Traps

HD is a frequent topic on the MCAT due to its interdisciplinary nature. Expect questions in the Biological and Biochemical Foundations section that test genetics (e.g., autosomal dominant inheritance, anticipation), and in the Psychological, Social, and Biological Foundations section that assess neuroanatomy and behavior. A common trap is confusing HD with other movement disorders; for instance, Parkinson's disease involves bradykinesia from direct pathway suppression, whereas HD causes chorea from indirect pathway disruption. Another pitfall is misremembering the gene location—it's on chromosome 4, not 7 or others. When faced with a vignette, look for keywords like "family history," "CAG repeats," "caudate atrophy," and "chorea" to pinpoint HD. Also, recall that psychiatric symptoms are core, not secondary, so answer choices that omit them may be incorrect. Practice integrating these concepts to solve questions efficiently.

Common Pitfalls

1. Incorrect Inheritance Pattern: Mistaking HD for an autosomal recessive or X-linked disorder. Correction: HD is autosomal dominant with complete penetrance; one mutated allele is sufficient.
2. Overemphasizing Motor Symptoms: Believing chorea is the sole hallmark. Correction: HD always includes progressive dementia and psychiatric features, which are critical for diagnosis and management.
3. Pathway Confusion: Thinking chorea results from direct pathway overactivity. Correction: It's primarily due to indirect pathway disruption from GABAergic neuron loss in the caudate, leading to reduced inhibition of movement.
4. Genetic Misconceptions: Assuming CAG repeat length only affects age of onset without impacting severity. Correction: Longer repeats correlate with earlier onset and often more rapid progression, a key point for genetic counseling.

Summary

• Huntington disease is an autosomal dominant disorder caused by a CAG trinucleotide repeat expansion in the huntingtin gene on chromosome four.
• Selective degeneration of GABAergic neurons in the caudate nucleus disrupts the indirect pathway of the basal ganglia, leading to chorea (involuntary dance-like movements) along with progressive dementia and psychiatric symptoms.
• Clinical diagnosis combines family history, motor and cognitive assessments, genetic testing, and neuroimaging showing caudate atrophy.
• Management is symptomatic and supportive, with no cure; multidisciplinary care is essential, and genetic counseling plays a crucial role.
• For the MCAT, focus on integrating genetics, neuroanatomy, and clinical presentation to distinguish HD from other disorders and avoid common traps like pathway or inheritance errors.
• Understanding HD pathology provides a foundation for broader concepts in neurodegeneration, making it a high-yield topic for exams and clinical practice.